Corporate News Releases Investors Business Contact
Growth & Excellence

 

 

 

2007

Nov. 29 MCVICAR ANNOUNCES NEW ORDER TO CHANGLONG

Nov. 29 MCVICAR ANNOUNCES THIRD QUARTER RESULTS

Nov. 22 MCVICAR ANNOUNCES STRATEGIC R & D PROGRAM WITH SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY DIVISION

Nov. 09 MCVICAR ANNOUNCES $25 MILLION SPECIALTY CHEMICAL ORDER

Nov. 01 MCVICAR ANNOUNCES MULTIYEAR ORDER FOR ANTI-ALZHEIMER'S DISEASE INTERMEDIATE CHEMICAL

Oct. 30 MCVICAR ANNOUNCES FIRST ORDER FOR ITS ANTI-AIDS INTERMEDIATE CHEMICAL

Oct. 26 MCVICAR ANNOUNCES APPROVAL OF CHANGLONG ACQUISITION

Sep. 20 MCVICAR ANNOUNCES RAPID PROGRESS IN EXPORT MARKET WITH KEY PRODUCT

Sep. 19 MCVICAR AMENDS ACQUISITION OF ADDITIONAL JITE SHARE PURCHASE

Sep. 07 MCVICAR ANNOUNCES STRATEGIC ORDER FROM DUPONT

Aug. 30 MCVICAR ANNOUNCES SECOND QUARTER RESULTS

Aug. 22 MCVICAR ISSUES STOCK OPTIONS

Aug. 03 MCVICAR ANNOUNCES NEW ACQUISITION

Jun. 21 MCVICAR ANNOUNCES SIGNIFICANT ORDER FROM DUPONT

Jun. 20 MCVICAR APPOINTS NEW DIRECTORS

May 07 MCVICAR APPOINTS NEW CHIEF FINANCIAL OFFICER

Apr. 23 MCVICAR COMPLETES ACQUISITION OF HONGBO

Apr. 10 MCVICAR CLOSES PRIVATE PLACEMENT

Mar. 09 MCVICAR RESOURCES ANNOUNCES PRIVATE PLACEMENT

Mar. 05 MCVICAR ISSUES STOCK OPTIONS

Feb. 23 MCVICAR'S HONGBO ACQUISITION APPROVED BY CHINESE GOVERNMENT

Jan. 19 MCVICAR RESOURCES ACQUIRES 51% OF JITE TECHNOLOGIES

 

McVICAR RESOURCES INC.
PRESS RELEASE
November 29, 2007
Trading Symbol: MCV

MCVICAR ANNOUNCES NEW ORDER TO CHANGLONG: McVicar Resources Inc. (“McVicar”) is pleased to announce that one of its China-based subsidiaries, Hangzhou Changlong Chemical Co. Ltd. (“Changlong”) has reached an agreement with a publicly listed Chinese pharmaceutical company for the purchase of its intermediate chemical, N-Ethylpiperazine, for use in Asthma drugs. The size of the order is 200 tonnes, valued at approximately 12 million RMB (~CDN $1.6 million) and is to be delivered in 2008. N-Ethylpiperazine is one of the key products for Changlong’s Piperazine series and has experienced rapid order growth since the end of 2006.

Changlong is a specialized developer and manufacturer of chemical intermediates for the pharmaceutical market. The main products are piperazine derivatives and pyridine derivatives. The company was founded in 1996 with approximately 100 employees. Changlong is among the top in expertise in China in reaction technology, particularly high pressure hydrogenation and ammonification. McVicar’s chemical subsidiary, McVicar (Hongkong) Advanced Materials Co. Ltd. (“MAM”) acquired 100% interest in Hongzhou Changlong Chemical Co. Ltd. (“Changlong”), China, in October, 2007. Changlong’s product lines complement McVicar’s other subsidiary Hongbo’s existing portfolio in the pharmaceutical markets.

“This is another encouraging development from our Chinese subsidiaries”, commented Dr. Gang Chai, President & CEO of McVicar, “With the increasing market demand for quality and stable medicines in China, Changlong stands a much better opportunity than its peers to grow its sales and market share based on the company’s advanced technology”.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
November 29, 2007
Trading Symbol: MCV

MCVICAR ANNOUNCES THIRD QUARTER RESULTS: McVicar Resources Inc. ("McVicar" or the "Company") is pleased to announce that it has filed its interim financial statements and management's discussion and analysis (MD&A) for the quarter ended September 30, 2007. The detailed financial statements and MD&A can be found on www.sedar.com.

McVicar reported revenues of $8.0 million, and net income of $0.25 million for the quarter ended September 30, 2007, compared with nil revenue and a net loss of $0.13 million in the same period of 2006. The net income for the third quarter of 2007 would have been $349,168 excluding adjustment for foreign exchange loss of $28,694 due to an increase in the Canadian dollar and stock option expenses of $69,844. Earnings per share were $0.01 for the third quarter of 2007.

For the nine months ended September 30, 2007, McVicar reported sales of $20.4 million and net income of $3.2 million. Earnings per share were $0.14 for the nine months of 2007, consistent with the first six months of 2007.

Business Highlights

In September 2007, McVicar purchased an additional 6,122,750 common shares (being 5.8% of the issued shares of JITE) from four shareholders of JITE for a total consideration of $3,061,375 or $0.50 per share to be satisfied by the issuance of 2,354,904 shares of McVicar at a deemed issue price of $1.30 per share. As a result, the Company’s total equity interest in JITE as of September 30, 2007 was 49,218,750 shares or 46.7%.

During this quarter, McVicar's subsidiary, Zhejiang Hongbo Chemical Co. Ltd, (“Hongbo”) made significant progress in penetrating international markets with its wide ranges of products, evidenced by a strategic order from DuPont USA for US $20 million over four years.

Hongbo generated sales of $2.94 million in the quarter, an increase of 108% or $1.5 million compared to $1.4 million for the second quarter of 2007, close to the total amount of $2.98 million for the first six months of 2007, mainly due to its significant progress in penetrating the international market such as orders to DuPont and its main chemical product series, the NPT series to a South Korean customer.

During this quarter, McVicar’s chemical subsidiary, McVicar (Hongkong) Advanced Materials Co. Ltd. (“MAM”), signed a letter of intent to acquire 100% interest in Hongzhou Changlong Chemical Co. Ltd. (“Changlong”), China. Changlong’s product lines complement Hongbo’s existing portfolio in the pharmaceutical markets.

"I am very pleased with the results," said Dr. Gang Chai, President and CEO. "We continue to see progress on all fronts in our investments and acquisitions as part of our China strategy. With all business foundations laid out, we are more confident for achieving faster growth in the near future."

Back to top

McVICAR RESOURCES INC.
PRESS RELEASE
November 22, 2007
Trading Symbol: MCV

MCVICAR ANNOUNCES STRATEGIC R&D PROGRAM WITH SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY DIVISION: McVicar Resources Inc. is pleased to announce that its key subsidiary, Hongbo Chemical Co. Ltd. (“Hongbo”) has reached a letter of agreement with the Division of Physical Organic Chemistry, Shanghai Institute of Organic Chemistry (“SIOC”) to start a strategic research and development program. The agreement is set for a period of three years with the initial objective for key product upgrade and development. The scope of the work will be focused on advancing Hongbo’s chemical agents used to optimize lithium batteries and for intermediate chemicals for the pharmaceutical industry.

Hongbo recognizes the scale and growth of the lithium battery market and the urgency in further developing its two current products to meet international demand. Hongbo’s current chemical agent quality is sufficient for the domestic Chinese market as proven recently with a three-year order from China-based Tinci High-Tech. Materials Co. Ltd.

The Shanghai Institute of Organic Chemistry is a member of the China Academy of Science and is the top research institute in organic chemistry in China. Hongbo has had a long-standing link to the SIOC for its original development of prototype products and for the selection of technologies of chemical synthesizing based on the standards of high yield, high selectivity and environmental friendliness. Hongbo’s key international customer DuPont was initially referred and assisted by SIOC. The agreement calls for full access to the facilities in the institute.

The research capability from the institute will provide efficient expertise in product development and quality improvement. In addition, with recent orders for Hongbo’s intermediate chemicals for various drugs by international companies, the institute will put great effort into developing product varieties and quality improvements to satisfy the growing need for consistent, high quality chemicals.

“This is a great development for our company in establishing a formal, cooperative relationship with an elite research institute in China”, commented Dr. Gang Chai, President & CEO of McVicar. “With continued access to the expertise, facilities and information, we are gaining great advantages over competitors for product improvement and invention. This will also enhance the ability of our chemical business to expand internationally.”

Zhejiang Hongbo Chemical Co. Ltd. is a wholly owned Chinese subsidiary of McVicar (Hong Kong) Advanced Material Co. Ltd. which is 51% owned by McVicar Resources Inc. through an equity acquisition earlier this year.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
November 9, 2007
Trading Symbol: MCV

MCVICAR ANNOUNCES $25 MILLION SPECIALTY CHEMICAL ORDER: McVicar Resources Inc. (“McVicar”) is pleased to announce that its Chinese subsidiary, Zhejiang Hongbo Chemical Co. Ltd. (“Hongbo”) has reached a three year supply agreement with Tinci High-Tech. Materials Co. Ltd. (“Tinci”) valued at RMB 200 million (~CDN $25 million). Under the terms of the agreement, Hongbo will supply Tinci with specialty chemicals used in personal care products and lithium batteries, beginning on January 1, 2008. Proportionately, the specialty chemicals used in personal care products represent approximately 80% of the order in terms of value, with the remaining 20% being specialty chemicals used in lithium batteries. In addition, under the terms of the agreement, Hongbo agrees to sell and deliver, and Tinci agrees to purchase and accept a minimum of 90% of the annual orders.

“I am extremely pleased with the signing of this major supply agreement by Hongbo, which follows a series of orders from major international companies in recent months. Hongbo’s emphasis on innovation and product quality has helped to build the company’s reputation, both domestically and internationally,” commented Dr. Gang Chai, President & CEO of McVicar, “We are confident that our chemical business will continue to experience rapid growth.”

The Tinci Group is located in Guangzhou, Southern China, and has businesses involved in specialty chemistry, pharmaceutical and environmental engineering. Since 2003, Tinci has been marketing Hongbo’s specialty chemicals, designed for application in the personal care products, to the second largest shampoo manufacturer in China. Through Tinci’s marketing efforts, Hongbo has previously sold between RMB 5 million to RMB 30 million to this shampoo manufacturer. Tinci was the largest customer to Hongbo before a DuPont order was recently received, valued at US $20 million. This new order represents the single largest order so far in the company’s history.

“We have been Hongbo’s largest customer for the last four years”, commented Mr. Jinfu Xu, Chairman of Tinci Group, “and we are very satisfied with the functionality and quality of the chemicals from Hongbo. The Tinci group understands the importance of securing a high quality and low cost supplier of specialty chemicals to partake in the rapid growth of China’s shampoo market.”

Zhejiang Hongbo Chemical Co. Ltd. is the wholly owned Chinese subsidiary of McVicar (Hongkong) Advanced Material Co. Ltd., which is 51% owned by McVicar through an equity acquisition earlier this year. Hongbo actively engages in the research, production and marketing of specialty chemicals for the personal care, pharmaceutical and industrial markets.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
November 1, 2007
Trading Symbol: MCV

MCVICAR ANNOUNCES MULTIYEAR ORDER FOR ANTI-ALZHEIMER’S DISEASE INTERMEDIATE CHEMICAL: McVicar Resources Inc. (“McVicar”) is pleased to announce that its Chinese subsidiary, Zhejiang Hongbo Chemical Co. Ltd. (“Hongbo”) has reached a letter of understanding with a major European pharmaceutical company for the purchase of its intermediate chemicals used in anti-Alzheimer’s drugs. The order was placed following a one year trial period of the product carried out by the pharmaceutical company. The new order is placed for 50 tonnes of the intermediate chemical which is valued at 10 million RMB (approximately US$1.4 million), and is to be delivered in 2008. Orders for subsequent years are expected to increase each year until 150 tonnes per year at a value of approximately 30 million RMB.

Alzheimer’s disease is a common disease among the elderly. The number of Alzheimer’s cases being reported is increasing mainly as a result of the large, aging segment of the global population. The intermediate chemical for anti-Alzheimer’s drugs is one of the earliest products developed by Hongbo in collaboration with the Shanghai Institute of Organic Chemistry.

“This multiyear order from an international pharmaceutical company is demonstrative of the high standard of our products. It is the direct result of the collaborative efforts between ourselves and one of China’s top Chemical Institutes, the Shanghai Institute of Organic Chemistry”, commented Dr. Gang Chai, President & CEO of McVicar, “We see tremendous opportunities for our products as a result of customer satisfaction and market demand.”

On Sept. 7, 2007, McVicar Resources Inc. announced that Hongbo had signed a long-term supply contract with Dupont valued at US$20 million. This contract followed an order from Dupont in June 2007, valued at US$1.78 million. More recently, on Sept. 20, 2007, Hongbo received an order valued at US$800,000 from a major South Korean company.  On Oct. 30, 2007, Hongbo received an initial order valued at US $700,000 for its anti-AIDS intermediate chemical from another South Korean company.

Zhejiang Hongbo Chemical Co. Ltd. is a wholly owned Chinese subsidiary of McVicar (Hongkong) Advanced Material Co. Ltd. which is 51% owned by McVicar Resources Inc.  Hongbo has developed over 30 advanced intermediate chemical products for the personal care, industrial and pharmaceutical industries with close cooperation with the leading chemical organization in China, the Shanghai Institute of Organic Chemistry under the China Academy of Sciences.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
October 30, 2007
Trading Symbol: MCV

MCVICAR ANNOUNCES FIRST ORDER FOR ITS ANTI-AIDS INTERMEDIATE CHEMICAL: McVicar Resources Inc. ("McVicar") is pleased to announce that its Chinese subsidiary, Zhejiang Hongbo Chemical Co. Ltd. ("Hongbo") has received an initial order for its intermediate chemicals used in anti-AIDS drugs from a major pharmaceutical company in South Korea. The order valued at approximately 5 million RMB calls for the immediate delivery of 6,000 kg of the intermediate chemical. The South Korean company also expressed its intention to purchase a further 5,000 kg of the intermediate chemical for future delivery.

“We are extremely excited about this breakthrough order of Hongbo’s intermediate chemicals used in anti-AIDS drugs. This marks the company’s successful penetration into a large, global market. Hongbo has been relying on research from one of China’s top research institutes, the Shanghai Institute of Organic Chemistry, to develop its products through a collaborative relationship. As a result of the company’s focus on R&D, and its dedication to product quality, Hongbo has obtained numerous international orders in recent months”, commented Dr. Gang Chai, President & CEO of McVicar, “This order is only the beginning of our multiple product offerings. We believe that the high standard of quality and low cost products will continue to further attract international orders.”

On Sept. 7, 2007, McVicar Resources Inc. announced that Hongbo had signed a long-term supply contract with Dupont valued at US$20 million. This contract followed an order from Dupont in June 2007, valued at US$1.78 million. More recently, on Sept. 20, 2007, Hongbo received an order valued at US$800,000 from a major South Korean company.

Zhejiang Hongbo Chemical Co. Ltd. is a wholly owned Chinese subsidiary of McVicar (Hongkong) Advanced Material Co. Ltd. which is 51% owned by McVicar Resources Inc.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
October 26, 2007
Trading Symbol: MCV

MCVICAR ANNOUNCES APPROVAL OF CHANGLONG ACQUISITION: McVicar Resources Inc. (“McVicar”) is pleased to announce that Hong Kong based McVicar (Hongkong) Advanced Materials Co. Ltd. (“MAM”) has been granted approval from all the relevant government authorities for the purchase of Changlong Chemical Co. Ltd. (“Changlong”) as originally announced on Aug. 3, 2007. Based on the purchase agreement, MAM will pay a cash amount of 20.50 million RMB (~CDN $2.70 million) and 9.5% of MAM’s shares, equivalent to a total of 30 million RMB (~CDN $3.95 million). In order to maintain its 51% controlling position in MAM, McVicar will invest a cash amount of 15.29 million RMB (~CDN $2.10 million) in the company. The new share holding structure of MAM will be McVicar (51%), Shining Palace (39.5%), and Changlong (9.5%).
Changlong is a developer, manufacturer and supplier of specialized fine chemical products used in the pharmaceutical industry. The company’s strength lies in its unique technologies for chemical synthesis under high pressure. Its customers are mainly Chinese pharmaceutical companies. Changlong reported revenue of more than 40 million RMB (~CDN $5.2 million) for the first nine months of the year.
McVicar Resources Inc. also announces that the share purchase of Jite Technologies Inc. previously announced Sept. 19, 2007 has successfully closed.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
September 20, 2007
Trading Symbol: MCV

MCVICAR ANNOUNCES RAPID PROGRESS IN EXPORT MARKET WITH KEY PRODUCT: McVicar Resources Inc. ("McVicar") is pleased to announce that its Chinese subsidiary Zhejiang Hongbo Chemical Co. Ltd. ("Hongbo") has made significant progress in penetrating the international market for one of its main product series, in the personal care industry. This comes on top of its recent success in obtaining multi-year orders from DuPont. During the months of June, July and August Hongbo successfully sold 128 mt of NPT (approximately US$800,000) to a major South Korean company. That quantity is approximately twice the amount that Hongbo sells to its domestic market for the dame period of time. It is expected that sales to the international market should grow more with further progress.
"It is great to hear that Hongbo made another inroad into the international market with one of its key products. The recognition of our products and services with more international companies clearly shows that Hongbo can provide high quality products with a reasonable price", commented Dr. Gang Chai, President & CEO of McVicar, "With continued efforts of Hongbo we believe there will be more orders and sales from other international companies.
Zhejiang Hongbo Chemical Co. Ltd. is the wholly owned Chinese subsidiary of McVicar (Hongkong) Advanced Materials Co. Ltd. which is 51% owned  by McVicar through an equity acquisition earlier this year.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
September 19, 2007
Trading Symbol: MCV

MCVICAR AMENDS ACQUISITION OF ADDITIONAL JITE SHARE PURCHASE: McVicar Resources Inc. (“McVicar”) announces that the Company has reduced its purchase of the shares of Jite Technologies Inc. (“JITE”) from 7,576,500 to 6,122,750 common shares (being 5.8% of the issued shares of JITE) from four shareholders rather than five shareholders as announced Sept. 10, 2007.  McVicar will purchase the shares for a total consideration of $3,061,375 or $0.50 per share to be satisfied by the issuance of 2,354,904 shares of McVicar Resources at a deemed issue price of $1.30 per McVicar share.

JITE Technologies, which was listed on the TSX Venture Exchange in July of 2006, designs and manufactures electronic connection devices for use in elevators, railways, security, and automation systems. JITE is headquartered in Toronto, Canada and carries out its research and manufacturing operations in Shenzhen, China.

Closing of the acquisition is subject to due diligence reviews by all parties and other conditions including compliance by the vendors with all applicable notice and other regulatory preconditions to the sale and the approval of all regulatory authorities having jurisdiction including, but not limited to the TSX Venture Exchange.

This acquisition will result in an increase in McVicar’s holdings in Jite from 43,096,000 to 49,218,750 shares or 46.7%. McVicar is purchasing these shares of JITE for investment purposes and McVicar has no plans to acquire any additional shares of JITE at this time.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
September 7, 2007
Trading Symbol: MCV

MCVICAR ANNOUNCES STRATEGIC ORDER FROM DUPONT: McVicar Resources Inc. (“McVicar”) is pleased to announce that the Company has signed a long-term strategic supply contract with DuPont of the USA through its Chinese subsidiary Zhejiang Hongbo Chemical Co. Ltd. (“Hongbo”). Under the long-term supply contract, DuPont has agreed to purchase approximately US$20 million dollars worth of chemical products from Hongbo over a period of four years. The contract will be automatically extended for two consecutive two-year terms if DuPont is satisfied with the products and services delivered by Hongbo. The long-term supply contract comes less than three months after Hongbo received an increased purchase order of US$1.78 million from DuPont. The chemical requested by DuPont is typically used in polycarbonates, epoxies, adhesives and coatings.

“I am extremely pleased with the recent positive developments from Hongbo. The company was able to earn increased confidence from one of the top quality chemical companies in the world and in such a short period of time”, commented Dr. Gang Chai, President & CEO of McVicar, “With an inventory of a series of high quality products developed previously, Hongbo is very well positioned to capture greater growth opportunities in the future”.

Zhejiang Hongbo Chemical Co. Ltd. is the wholly owned Chinese subsidiary of McVicar (Hongkong) Advanced Material Co. Ltd. which is 51% owned by McVicar through an equity acquisition earlier this year.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
August 30, 2007
Trading Symbol: MCV

MCVICAR ANNOUNCES SECOND QUARTER RESULTS: McVicar Resources Inc. (“McVicar” or the “Company”) is pleased to announce that it has filed its interim financial statements and management's discussion and analysis (MD&A) for the quarter ended June 30, 2007. The detailed financial statements and MD&A can be found on www.sedar.com

McVicar reported revenues of $6.3 million, and net income of $2.6 million for the quarter ended June 30, 2007, compared with nil revenue and a net loss of $0.07 million in the same period of 2006. The Company’s continued profitable performance follows its first ever profitable quarter earlier this year. In the first quarter of 2007 McVicar reported net earnings of $0.3 million. The significant increase was mainly due to a $2.4 million deemed investment gain on its equity interest in JITE, which is a TSX Venture listed company which McVicar acquired a controlling interest of in January, 2007. Net income excluding gain on deemed disposal for the three months ended June 30, 2007 was $242,952 after adjusting for foreign exchange loss of $99,736 due to an increase in the Canadian dollar and stock option expenses of $50,000. Earnings per share were $0.11 for the second quarter of 2007 compared to a loss of $0.01 per share for the same period in 2006.

Revenues for the first six months of 2007 amounted to $12.4 million and net income was $2.9 million, a $0.13 earning per share for the first half of 2007.

“I am very excited with McVicar’s breakthrough achievements.” said Gang Chai, McVicar’s President and CEO. “We continue to see progress on all fronts in our investments and from recent acquisitions as part of our China strategy. The Companies we have an interest in have been gaining positive international commercial recognition. Jite Technologies continues to add global companies such as Otis and Molex of the USA as its customers. McVicar’s chemical subsidiary, Zhejiang Hongbo Chemical Co. Ltd. received its first major purchase order of US $1.78 million from DuPont of the USA. We are confident that McVicar will achieve extraordinary growth with our strategy of expanding in China”.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
August 22, 2007
Trading Symbol: MCV

MCVICAR ISSUES STOCK OPTIONS: McVicar Resources Inc. ("McVicar") announces that it has granted incentive stock options in respect of 190,000 shares exercisable at $1.10 per share for a period of two years to a new director and a new CFO and employees of the Company. The shares were granted in consideration of the positive growth in McVicar with the successful acquisition of interests in the Chinese chemical and technology industries.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
August 3, 2007
Trading Symbol: MCV

MCVICAR ANNOUNCES NEW ACQUISITION: McVicar Resources Inc. (“McVicar”) is pleased to announce that its 51% owned subsidiary, McVicar (Hongkong) Advanced Materials Co. Ltd. (“MAM”) has signed a letter of intent to acquire 100% interest in Hongzhou Changlong Chemical Co. Ltd. (“Changlong”) that is based in Zhejiang province, China. MAM will pay a cash amount of 20.50 million RMB, (CDN $2.88 million), and 9.5% of MAM’s shares (equivalent to 30 million RMB) to Changlong.
In order to maintain a 51% controlling interest, McVicar will pay a cash amount of 15.29 million RMB (CDN $2.14 million) to MAM. The new share holding structure of MAM will be McVicar (51%), Shining Palace (39.5%) and Changlong (9.5%). MAM will advance a payment of 2 million RMB to Changlong upon signing the agreement. Changlong will apply for all required government approvals.

Changlong is a developer, manufacturer and supplier of specialized fine chemical products used in the pharmaceutical industry. The company’s technology synthesizes chemicals under high pressure. Its customers are mainly Chinese pharmaceutical companies. The company is in a phase of an accelerated growth. In 2006, Changlong generated revenue of approximately 35 million RMB (CDN $5 million) and management expects to generate more than 5 million RMB (CDN $700,000) in gross profit for fiscal year 2007.

“I am pleased with this new acquisition. It is a further step for McVicar to add new lines of technology and products to our intermediate chemicals for the pharmaceutical industry”, Dr. Gang Chai, McVicar’s CEO, commented. “McVicar is making great progress in achieving its strategy to establish a full chain of intermediate chemicals in the pharmaceutical, personal care and lithium battery industries started from our core holding in Zhejiang Hongbo Chemical Co. Ltd.”

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
June 21, 2007
Trading Symbol: MCV

MCVICAR ANNOUNCES SIGNIFICANT ORDER FROM DUPONT: McVicar Resources Inc. (the “Company”, “McVicar”) is pleased to announce that its Chinese subsidiary, Zhejiang Hongbo Chemical Co. Ltd. (“Hongbo”) has received an increased purchase order from DuPont of the USA for one of its main chemical products. The order has increased in size by 165% from the original order to US $1.78 million. Delivery of the product is scheduled monthly for the next 10 months. The chemical requested by DuPont is typically used in polycarbonates, epoxies, adhesives and coatings.

“We are very pleased with the increased interest from a world leading chemical company”, said Dr. Gang Chai, President & CEO of McVicar, “Hongbo represents an important investment for McVicar. We are pleased to see this great success early in our relationship with Hongbo”.

Zhejiang Hongbo Chemical Co. Ltd. is the wholly owned Chinese subsidiary of McVicar (Hongkong) Advanced Material Co. Ltd. which is 51% owned by McVicar through an equity acquisition earlier this year.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
June 20, 2007
Trading Symbol: MCV

MCVICAR APPOINTS NEW DIRECTORS: At the Annual General and Special Meeting of the shareholders of McVicar Resources Inc. on June 19, 2007 was the election of Gang Chai, D. James Misener, Raymond Morley, Anthony Naldrett, and Kang Hongjie to the Company's Board of Directors. Mr. Kang Hongjie is newly elected to the Board of Directors, with Paul Lin, John Paterson and Exavier Peterson not returning.

Mr. Kang Hongjie is the General Manager of Zhejiang Hongbo Chemical Co., Zhejiang Province, China, a wholly owned subsidiary of Hongkong McVicar Advanced Materials Co. Ltd. of which McVicar Resources Inc. owns a 51% interest. Mr. Kang received his B.Sc. degree in chemistry from Wuhan University in 1985, and M.Sc. from the Shanghai Institute of Organic Chemistry in 1990. He worked for several Pharmaceutical and Chemical Companies for over 10 years before joining Hongbo as general manager in 2003.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
May 7, 2007
Trading Symbol: MCV

MCVICAR APPOINTS NEW CHIEF FINANCIAL OFFICER: McVicar Resources Inc. (the “Company”, “McVicar”) is pleased to announce the appointment of Mr. Henry Tse as Chief Financial Officer of the Company, subject to regulatory approval. Henry Tse, CFO, is a Chartered Accountant, Certified Financial Planner and a senior partner in Choong and Associates Chartered Accountants LLP, in Toronto. Prior to joining Choong and Associates in 1993 Mr. Tse was an audit manager with Sun Life Assurance of Canada for two years and audit manager with Ernst & Young LLP for five years. He has been CFO of Jite Technologies Inc. (TSX.V “JTI”), and Jite Connectors Inc. the predecessor company of Jite Technologies Inc., since October 2005.  McVicar acquired a 51% equity interest in Jite in January 2007. Mr. Tse will be responsible for accounting, financial management and corporate compliance of the Company.

Dr. Paul Lin has resigned as Chief Financial Officer of the Company.  Dr. Lin has been a director and CFO of McVicar since the Company was listed on the TSX Venture Exchange in 2004.

“I am delighted with the appointment of Mr. Henry Tse to our senior management team.” commented Dr. Gang Chai, President and CEO of McVicar Resources Inc. “This is a particularly exciting time for McVicar as the Company has successfully transformed from a junior mining company to a cash flow company by being in several industries in the growing economy in China. The financial experience and expertise of Mr. Tse are of great value to McVicar for its continuing pursuit of growth in China.”

McVicar is expected to report revenue and profit in the first quarter of 2007.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
April 23, 2007
Trading Symbol: MCV

MCVICAR COMPLETES ACQUISITION OF HONGBO: McVicar Resources Inc. (“McVicar”) is pleased to announce that it has made the final payment of 15.30 million RMB (approximately CDN$ 2.175 million) to Shining Palace Holding Limited to complete its acquisition of 51% of Hong Kong based McVicar (Hong Kong) Advanced Materials Co. Ltd. (“MAM”) as originally announced on October 27, 2006. Shining Palace Holding Limited, the seller of the 51% interest in MAM is entirely at arm’s length to McVicar.  The total acquisition to the 51% interest in MAM was 30.60 million RMB (approximately CDN $4.35 million) all of which was paid in cash. No securities of McVicar were issued in consideration of the acquisition.

MAM owns a 100% interest in Zhejiang Hongbo Chemical Co. Ltd., China (“Hongbo”) which develops, manufactures and supplies specialized fine chemical products for the pharmaceutical and cosmetic industries. Hongbo’s customers include major international and Chinese chemical companies. The company has experienced 100% growth for each of the last three years and is expected to continue rapid growth in the future. In addition, Hongbo has developed a large number of new products that are expected to sustain the company’s aggressive growth.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
April 10, 2007
Trading Symbol: MCV

MCVICAR CLOSES PRIVATE PLACEMENT: McVicar Resources Inc. (“McVicar”) (TSX-V “MCV”) announces the closing of its private placement announced on March 9th. , 2007. A total of 2,500,000 common shares were placed to 3 placees resident in The Peoples Republic of China, yielding gross proceeds of $2,250,000 or $0.90 per share. These shares will be subject to a hold period of 4 months and one day from the date of closing expiring August 11, 2007. A cash finders’ fee of $112,500 or 5% was paid to an unrelated, arm’s length party in connection with this placement.

The proceeds from the offering are used to pay the balance of the acquisition of a 51-per-cent equity interest in McVicar (Hongkong) Advanced Materials Co. Ltd. ("MAM") that was reported and filed via SEDAR on October 27, 2006.  MAM owns a 100-per-cent interest in Zhejiang Hongbo Chemical Co. Ltd., China.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
March 9, 2007
Trading Symbol: MCV

MCVICAR RESOURCES ANNOUNCES PRIVATE PLACEMENT: McVicar Resources Inc. ("McVicar") is pleased to announce that it has arranged a non-brokered private placement for gross proceeds of approximately 16,000,000 RMB (approx. $2.5 million CDN). The offering, priced at $0.90 per share, will result in the issuance of approximately 2,700,000 common shares of McVicar.

Proceeds from the offering will be used to complete the remaining payment to the Shareholders of McVicar (Hong Kong) Advanced Materials Co. Ltd. (“MAM”) as announced in the press release dated February 23, 2007. The common shares will be subject to a six-month hold period upon closing of the private placement. A finder’s fee will be paid in connection with the private placement. The offering is subject to approval by the TSX Venture Exchange.

McVicar is a TSX Venture Exchange listed company engaged in mineral exploration, chemical production and the technology industry. Most of its business activities are focused in China.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
March 5, 2007
Trading Symbol: MCV

MCVICAR ISSUES STOCK OPTIONS: McVicar Resources Inc. ("McVicar") announces that it has granted incentive stock options in respect of 210,000 shares exercisable at $0.75 per share for a period of two years to directors and consultants  of the Company. The shares were granted in consideration of the positive growth in McVicar with the successful acquisition of interests in the Chinese chemical and technology industries.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
February 23, 2007
Trading Symbol: MCV

MCVICAR'S HONGBO ACQUISITION APPROVED BY CHINESE GOVERNMENT: McVicar Resources Inc. ("McVicar") is pleased to announce that Hong Kong based McVicar (Hong Kong) Advanced Materials Co. Ltd. (“MAM”) has officially completed the purchase of 100% interest in Zhejiang Hongbo Chemical Co. Ltd., China (“Hongbo”) from Shining Palace Holding Limited with the approval of the Chinese Government as originally announced on October 27, 2006.
To acquire 51% interest in MAM, McVicar will pay a cash amount of 30.60 million RMB (approximately CDN $4.35 million) of which McVicar has paid 50% of the total amount to the shareholders of MAM. The other 50% of cash will be paid before the end of March, 2007. By converting China-based Hongbo Chemical into a foreign owned entity, the company is eligible for the tax benefit of a two-year income tax holiday and another three subsequent years at half the prescribed corporate income tax rate in China.
Hongbo develops, manufactures and supplies specialized fine chemical products for the pharmaceutical and cosmetic industries. Hongbo’s customers include major international and Chinese chemical companies. The company has experienced 100% growth for each of the last three years and is expected to continue rapid growth in the future. In addition, Hongbo has developed a large number of new products that are expected to sustain the company’s aggressive growth.

“This acquisition, in addition to the recent acquisition of Jite Technologies, which is listed on the TSX Venture Exchange, marks the turning point of McVicar to transform into a cash flow business. It is also a milestone in our advance in the fine chemical industry as McVicar made significant investment in Nanjing Sino-Lion Chemical Co. Ltd.,” commented Dr. Gang Chai, McVicar’s CEO. “I am confident that we will see improved operations at our recent acquisitions from our exposure to the capital market and introduction of western management.”
McVicar will also take full advantage of future cash flows generated from the operating companies to fuel further growth in China.

Back to top

 

McVICAR RESOURCES INC.
PRESS RELEASE
Jan 19, 2007
Trading Symbol: MCV

MCVICAR RESOURCES ACQUIRES 51% OF JITE TECHNOLOGIES: McVicar Resources Inc. (TSX-V 'MCV') is pleased to announce the closing on January 19, 2007 of its transaction, previously announced on December 15, 2006, whereby it acquired from the four major shareholders of Jite Technologies (“Jite”) 42,500,000 common shares of Jite (being 51.12% of the issued shares of Jite) from those same shareholders.

Under the agreement, McVicar purchase 42,500,000 shares (of which 27,600,000 shares remain subject to escrow under the policies of the TSX Venture Exchange) being 51.12% of the outstanding common shares of Jite from Jiming Liu, XiaoJian Yu (both of Bakersfield, California, U.S.A.), Changlin Qin and Jing Tang (both of Toronto, Ontario), all of whom currently hold an aggregate of 63,921,000 common shares of Jite, for a total consideration of $5,312,500 which was satisfied by a combination of $1,375,000 cash and 4,375,000 shares of McVicar Resources at a deemed issue price of $0.90 per McVicar share. A total of $600,000 of the cash consideration will be paid on closing and the remaining $775,000 will be paid on July 18, 2007.

Dr. Gang Chai, the CEO of McVicar has been appointed a Director and Chairman of the Board of Jite.

McVicar purchased these shares of Jite for investment purposes and McVicar has no plans to acquire any additional shares of Jite at this time.  McVicar Resources has recently acquired interests in numerous other successful China-based industrial businesses. The acquisition of Jite follows McVicar’s strategy of acquiring businesses that purposefully fit with its overall China strategy.

For further Information, please contact Dr. Gang Chai at: 55 University Avenue, Suite 605, Toronto, ON M5J 2H7 Tel: (416)366-7420 Fax (416)366-7421
The TSX Venture Exchange has not reviewed and does not accept responsibility for these news releases.

Back to top

 

 

Copyright © 2008 McVicar Industries Inc. All Rights Reserved